San Diego-headquartered Illumina, a leader in DNA sequencing and array-based technologies, said it will establish a Global Capability Center (GCC) in Bengaluru as part of its plans to expand the ...

By combining Biosearch Technologies' targeted genotyping-by-sequencing library preparation methodology (Amp-Seq) with Illumina's proven and highly scalable sequencing technology, the partnership ...

After hours: September 27 at 4:45 PM EDT ...

The Dutch competition watchdog is seeking beefed-up powers to probe more small deals that risk crushing competition in ...

Though Illumina said goodbye to Grail this past ... of Grail could tempt it to wield its massive market share in DNA sequencing, and throttle back the research of its rivals in cancer screening.

Better View For Scientific Insights Medical research is highly dependent on studies on animal models, and our progress in medicine has been deeply influenced by better analytical methods, ...

The DNA sequencing and array-based technologies provider noted that the court ruled that the European Commission did not have jurisdiction over Illumina's acquisition of GRAIL. According to the ...

Illumina Inc., a key player in DNA sequencing and array-based technologies, on Friday that it will establish a Global Capability Center in Bengaluru, India, as an investment to expand its ...

BENGALURU: Illumina, a global leader in DNA sequencing and array-based technologies, announced it will establish a Global CapabilityCenter in Bengaluru to expand its technology workforce in ...

The MiSeq desktop sequencer offers low throughput flowcells and long read lengths. It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The ...

The legal vindication arrives too late for Illumina, the U.S. gene-sequencing powerhouse, which spun off Grail as a stand-alone public company this summer to comply with government orders.